Offer - Urjas Oil for just ₹ 1 X
Alsita M IR Tablet is an allopathic medicine The correct dosage of Alsita M IR Tablet depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Alsita M IR Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Alsita M IR Tablet safe for pregnant women?
Alsita M IR Tablet has little to no side effects in pregnant women.
Is the use of Alsita M IR Tablet safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Alsita M IR Tablet. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Alsita M IR Tablet on the Kidneys?
Alsita M IR Tablet is not harmful for kidneys.
What is the effect of Alsita M IR Tablet on the Liver?
Alsita M IR Tablet is not harmful for the liver.
What is the effect of Alsita M IR Tablet on the Heart?
Using Alsita M IR Tablet does not have any harmful effects on the heart.
Alsita M IR Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Alsita M IR Tablet unless your doctor advises you to do so -
Is this Alsita M IR Tablet habit forming or addictive?
No, you will not get addicted to Alsita M IR Tablet.
Interaction between Food and Alsita M IR Tablet
There isn't any research available on the side effects of taking Alsita M IR Tablet with food.
Interaction between Alcohol and Alsita M IR Tablet
Consult your doctor before consuming alcohol while taking Alsita M IR Tablet as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Januvia® (sitagliptin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 274-275
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1143-1144
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826